Quick Answer
China SXT Pharmaceuticals, Inc. reported Total Assets of $21.66 million for the year ending 2025.
- China SXT Pharmaceuticals, Inc. showed a decrease of -6.3% in Total Assets from 2024 to 2025.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), China SXT Pharmaceuticals, Inc.'s Total Assets has grown by 182.9%.
- Historical annual values: Fiscal year 2025: $21.66 million | Fiscal year 2024: $23.13 million | Fiscal year 2023: $29.55 million | Fiscal year 2022: $33.55 million | Fiscal year 2021: $34.55 million | Fiscal year 2020: $21.70 million | Fiscal year 2019: $17.47 million | Fiscal year 2018: $7.66 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: